James Sapirstein - Chief Executive Officer at Cocrystal Pharma, Inc.

Issuer-level insider activity

Role
Chief Executive Officer
Issuer ticker
COCP on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by James Sapirstein since 11 Jul 2025

Reported holdings for James Sapirstein in Cocrystal Pharma, Inc.

Form 4 holding Chief Executive Officer

Cocrystal Pharma, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
235,000
Estimated value
Report date
03 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for James Sapirstein in Cocrystal Pharma, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .